Skip to main content
. 2022 Feb 23;37(16):4168–4175. doi: 10.1007/s11606-022-07433-4

Table 4.

Medical and Surgical Complications and Additional Procedures Performed Within 30 Days of Placement of a Medicaid-Funded Long-Acting Contraceptive Procedure Provided to California Patients, 2008–2014

Levonorgestrel IUC (n = 35,705) Copper IUC (n = 23,628) Laparoscopic tubal ligation (n = 23,965)
Medical complications*
Acute cardiovascular event 15 (0.04%) < 11 (< 0.01%) 41 (0.17%)
Deep vein thrombosis or pulmonary embolism 16 (0.04%) 13 (0.06%) 28 (0.12%)
Anesthetic/respiratory complications 57 (0.16%) 30 (0.13%) 172 (0.72%)
Infection 112 (0.31%) 93 (0.39%) 698 (2.91%)
Surgical complications
Acute hemorrhage 12 (0.03%) < 11 (< 0.01%) 192 (0.80%)
Abdominal injury 124 (0.35%) 65 (0.28%) 713 (2.98%)
Cervical laceration < 11 (< 0.01%) 0 (0%) 15 (0.06%)
Additional procedures
Hysterectomy < 11 (< 0.01%) 0 (0%) 948 (3.96%)
Salpingectomy 0 (0%) 0 (0%) 950 (3.96%)
Oophorectomy < 11 (< 0.01%) 0 (0%) 1887 (7.87%)
Laparoscopy 15 (0.04%) < 11 (< 0.01%) 335 (1.40%)
Hysteroscopy 36 (0.10%) < 11 (< 0.01%) 922 (3.85%)

Excluding procedures performed within 42 days of a birth. Statistically significant with p < 0.05 for all comparisons of tubal ligation to IUC shown in the table. Data are n (%); CMS guidance limits presentation of cells with n less than 11

*ICD-9 codes used to define each variable are available from authors by request

Claims data do not allow identification of whether additional procedures were planned in advance